TUMOLO ANNETTE 4
4 · BIO-RAD LABORATORIES, INC. · Filed Nov 15, 2021
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIOB
TUMOLO ANNETTE
Executive Vice President
Transactions
- Exercise/Conversion
Bio-Rad A Common Stock
2021-11-11$333.34/sh+500$166,670→ 5,706.348 total - Exercise/Conversion
Bio-Rad A Common Stock
2021-11-11$333.34/sh+613$204,337→ 5,206.348 total - Exercise/Conversion
Bio-Rad A Common Stock
2021-11-11$524.30/sh+433$227,022→ 6,139.348 total - Sale
Bio-Rad A Common Stock
2021-11-11$748.08/sh−433$323,919→ 5,706.348 total - Sale
Bio-Rad A Common Stock
2021-11-11$748.84/sh−613$459,039→ 5,093.348 total - Sale
Bio-Rad A Common Stock
2021-11-11$750.00/sh−500$375,000→ 4,593.348 total - Exercise/Conversion
Bio-Rad A Common Stock
2021-11-12$159.32/sh+600$95,592→ 5,193.348 total - Exercise/Conversion
Bio-Rad A Common Stock
2021-11-12$215.98/sh+2,400$518,352→ 7,593.348 total - Exercise/Conversion
Bio-Rad A Common Stock
2021-11-12$326.15/sh+1,800$587,070→ 9,393.348 total - Sale
Bio-Rad A Common Stock
2021-11-12$750.05/sh−4,800$3,600,240→ 4,593.348 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-11-11−433→ 1,300 totalExercise: $524.30Exp: 2030-09-02→ Bio-Rad A Common Stock (433 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-11-11−1,113→ 1,671 totalExercise: $333.34Exp: 2029-09-03→ Bio-Rad A Common Stock (1,113 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-11-12−1,800→ 1,200 totalExercise: $326.15Exp: 2028-09-04→ Bio-Rad A Common Stock (1,800 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-11-12−2,400→ 600 totalExercise: $215.98Exp: 2027-09-05→ Bio-Rad A Common Stock (2,400 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-11-12−600→ 0 totalExercise: $159.32Exp: 2026-09-07→ Bio-Rad A Common Stock (600 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.61, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option, representing a right to purchase a total of 1,733 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted.
- [F3]The option, representing a right to purchase a total of 2,784 shares, became exercisable in five equal annual installments beginning on September 3, 2020, which was the first anniversary of the date on which the option was granted.
- [F4]The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.
- [F5]The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.
- [F6]The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.